Hereditary angioedema:: Aesthetic and quality of life changes derived from the illness itself and the attenuated androgens treatment

被引：0
|
作者：
Traseira, C. Gomez [1 ]
Pedrosa, M. [1 ]
Caballero, T. [1 ]
Prior, N. [1 ]
Jurado, J. [1 ]
Cabanas, R. [1 ]
Lopez-Serrano, M. [1 ]
机构：
[1] Univ Hosp La Paz, Dept Allergy, Madrid, Spain
来源：
ALLERGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [21] Lanadelumab improves health-related quality of life in patients with hereditary Angioedema (HAE): findings from the HELP study
    Longhurst, Hilary
    Lumry, William
    Weller, Karsten
    Magerl, Markus
    Lu, Peng
    Jain, Gagan
    Lewis, Hannah
    Maurer, Marcus
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1524 - 1525
  • [22] Garadacimab prophylaxis improves quality of life in adult and adolescent patients with hereditary angioedema: Results from a multicentre Phase 3 study
    Lumry, W.
    Magerl, M.
    Craig, T. J.
    Farkas, H.
    Yang, W.
    Stroes, E. S.
    Saguer, I. Martinez
    Aygoeren-Puersuen, E.
    Staubach, P.
    Treudler, R.
    Itzler, R.
    Feuersenger, H.
    Pragst, I.
    Reshef, A.
    ALLERGY, 2023, 78 : 114 - 115
  • [23] Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered c1 inhibitor in patients with hereditary angioedema
    Zanichelli, A.
    Azin, G.
    Federico, C.
    Vacchini, R.
    Caballero, T.
    ALLERGY, 2018, 73 : 725 - 725
  • [24] PATIENTS RECEIVING C1-INH TREATMENT FOR HEREDITARY ANGIOEDEMA REPORT FEW HEALTH-RELATED LIMITATIONS ON QUALITY OF LIFE SURVEY
    Bewtra, A.
    Levy, R.
    Wasserman, R.
    Jacobson, K.
    Craig, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A115 - A115
  • [25] Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study
    Watt, Maureen
    Maurer, Marcus
    Lumry, William
    Li, H. Henry
    Aygoeren-Puersuen, Emel
    Busse, Paula
    Jacobs, Joshua
    Nurse, Christina
    Yu, Ming
    Romanus, Dorothy
    Devercelli, Giovanna
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB139 - AB139
  • [26] TREATMENT OF HEREDITARY ANGIO-EDEMA BY LOW-DOSE ATTENUATED ANDROGENS - DISASSOCIATION OF CLINICAL-RESPONSE FROM LEVELS OF CI ESTERASE INHIBITOR AND C-4
    WARIN, AP
    GREAVES, MW
    GATECLIFF, M
    WILLIAMSON, DM
    WARIN, RP
    BRITISH JOURNAL OF DERMATOLOGY, 1980, 103 (04) : 405 - 409
  • [27] Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study
    Andrea Zanichelli
    Giulia Maria Azin
    Federico Cristina
    Romualdo Vacchini
    Teresa Caballero
    Orphanet Journal of Rare Diseases, 13
  • [28] Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study
    Zanichelli, Andrea
    Azin, Giulia Maria
    Cristina, Federico
    Vacchini, Romualdo
    Caballero, Teresa
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [29] Who benefits from digital interventions for bipolar disorder? Stage of illness characteristics as predictors of changes in quality of life
    Tremain, Hailey
    Fletcher, Kathryn
    Meyer, Denny
    Murray, Greg
    BIPOLAR DISORDERS, 2024, 26 (07) : 684 - 695
  • [30] Subgroup analyses of treatment response to plasma-derived C1 esterase inhibitor based on prospective data from treatment of 1085 acute hereditary angioedema attacks
    Bernstein, J.
    Bewtra, A.
    Hurewitz, D.
    Wasserman, R.
    Machnig, T.
    Keinecke, H.
    Craig, T.
    ALLERGY, 2011, 66 : 419 - 420
12345